XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income (loss) $ (24.5) $ (23.0)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 69.2 56.5
Stock-based compensation expense 45.0 37.2
(Gain) loss from derivatives, sale of investments and other assets and foreign currency, net 26.6 (9.0)
Noncash lease expense 3.9 4.2
Noncash interest expense 1.6 13.2
Change in deferred income taxes and other (9.3) (15.2)
Changes in operating assets and liabilities:    
Accounts receivable, net 8.2 (59.5)
Prepaid expenses and other assets (19.2) (2.0)
Accounts payable (46.3) (18.8)
Deferred revenue 4.3 40.4
Income tax payable (30.0) 5.9
Operating lease and other liabilities (232.2) (193.6)
Net cash provided by (used in) operating activities (202.7) (163.7)
Cash flows from investing activities:    
Purchases of investments (2.2) (537.2)
Maturities of investments 84.8 83.9
Sales of investments 74.0  
Acquisition of property and equipment (10.3) (1.7)
Business combinations, net of cash acquired (12.6) (19.6)
Release of restricted cash escrow from business combinations (120.0)  
Asset acquisitions of intangible assets (1.0) (0.9)
Other investing activities, net (20.4) (0.3)
Net cash provided by (used in) investing activities (7.7) (475.8)
Cash flows from financing activities:    
Debt issuance costs paid   (0.9)
Taxes paid related to net share settlement of stockholders' equity awards (5.7) (8.2)
Proceeds from issuance of common stock 7.3 10.5
Acquisition-related contingent consideration payments (56.6) (25.1)
Net cash provided by (used in) financing activities (55.0) (23.7)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (12.6) (1.7)
Net change in cash, cash equivalents and restricted cash (278.0) (664.9)
Cash, cash equivalents and restricted cash, beginning of period 1,185.2 1,500.4
Cash, cash equivalents and restricted cash, end of period $ 907.2 835.5
Noncash investing activities:    
Acquisition-related deferred purchase consideration   $ 1.5